IL212905A0 - Individualized cancer dignosis - Google Patents

Individualized cancer dignosis

Info

Publication number
IL212905A0
IL212905A0 IL212905A IL21290511A IL212905A0 IL 212905 A0 IL212905 A0 IL 212905A0 IL 212905 A IL212905 A IL 212905A IL 21290511 A IL21290511 A IL 21290511A IL 212905 A0 IL212905 A0 IL 212905A0
Authority
IL
Israel
Prior art keywords
dignosis
individualized cancer
individualized
cancer
cancer dignosis
Prior art date
Application number
IL212905A
Original Assignee
Collabrx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Collabrx Inc filed Critical Collabrx Inc
Publication of IL212905A0 publication Critical patent/IL212905A0/en

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/10—Ploidy or copy number detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
IL212905A 2008-11-18 2011-05-16 Individualized cancer dignosis IL212905A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11589808P 2008-11-18 2008-11-18
PCT/US2009/065011 WO2010059742A1 (en) 2008-11-18 2009-11-18 Individualized cancer treatment

Publications (1)

Publication Number Publication Date
IL212905A0 true IL212905A0 (en) 2011-07-31

Family

ID=41683176

Family Applications (1)

Application Number Title Priority Date Filing Date
IL212905A IL212905A0 (en) 2008-11-18 2011-05-16 Individualized cancer dignosis

Country Status (4)

Country Link
US (1) US10262103B2 (en)
EP (1) EP2366162A1 (en)
IL (1) IL212905A0 (en)
WO (1) WO2010059742A1 (en)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9499864B2 (en) 2003-11-03 2016-11-22 Aab Patent Holding Aps Expression of FABP4 and other genes associated with bladder cancer progression
WO2010028288A2 (en) 2008-09-05 2010-03-11 Aueon, Inc. Methods for stratifying and annotating cancer drug treatment options
US20130143747A1 (en) * 2011-12-05 2013-06-06 Myriad Genetics, Incorporated Methods of detecting cancer
EP2499261A4 (en) * 2009-11-10 2013-05-15 Gema Diagnostics Inc Genes differentially expressed by cumulus cells and assays using same to identify pregnancy competent oocytes
US10192641B2 (en) * 2010-04-29 2019-01-29 The Regents Of The University Of California Method of generating a dynamic pathway map
CA2796272C (en) 2010-04-29 2019-10-01 The Regents Of The University Of California Pathway recognition algorithm using data integration on genomic models (paradigm)
CN102269766B (en) * 2010-06-01 2015-08-26 北京大学 The application of human gene FAM96A and protein thereof
SG186953A1 (en) 2010-07-09 2013-02-28 Somalogic Inc Lung cancer biomarkers and uses thereof
CN106198980B (en) 2010-08-13 2018-09-07 私募蛋白质体公司 Cancer of pancreas biomarker and application thereof
WO2012027716A1 (en) 2010-08-27 2012-03-01 Collabrx, Inc. Method to treat melanoma in braf inhibitor-resistant subjects
EP3572528A1 (en) 2010-09-24 2019-11-27 The Board of Trustees of the Leland Stanford Junior University Direct capture, amplification and sequencing of target dna using immobilized primers
US20120077695A1 (en) * 2010-09-27 2012-03-29 Somalogic, Inc. Mesothelioma Biomarkers and Uses Thereof
NZ589251A (en) 2010-11-12 2014-07-25 Pacific Edge Ltd Novel marker for detection of bladder cancer
CN102183655B (en) * 2011-01-24 2014-06-11 中国人民解放军军事医学科学院生物医学分析中心 New molecular marker CUEDC2 (CUE Domain Containing 2) protein for prognosis judgement in endocrine therapy of breast cancer
KR101371697B1 (en) * 2011-02-07 2014-03-07 연세대학교 원주산학협력단 Patient-Tailored Cancer Chemotherapy
US20120238464A1 (en) * 2011-03-18 2012-09-20 Baylor Research Institute Biomarkers for Predicting the Recurrence of Colorectal Cancer Metastasis
CN102772803A (en) * 2011-05-12 2012-11-14 北京大学 Applications of UNC5CL and its coding protein
EP2721181B1 (en) 2011-06-17 2019-12-18 Myriad Genetics, Inc. Methods and materials for assessing allelic imbalance
DK2748192T3 (en) * 2011-08-23 2019-02-25 Found Medicine Inc KIF5B-RET-FUSION MOLECULES AND APPLICATIONS THEREOF
WO2013055911A1 (en) 2011-10-14 2013-04-18 Dana-Farber Cancer Institute, Inc. Znf365/zfp365 biomarker predictive of anti-cancer response
US20130144887A1 (en) * 2011-12-03 2013-06-06 Medeolinx, LLC Integrative pathway modeling for drug efficacy prediction
WO2013132440A1 (en) * 2012-03-07 2013-09-12 Manuel Gidekel Tumor biomarkers for pancreatic cancer
EP2861766B1 (en) 2012-06-13 2018-08-08 King Abdullah University Of Science And Technology Methylation biomarkers for breast cancer
WO2014038884A1 (en) * 2012-09-07 2014-03-13 주식회사 마크로젠 Fusion protein and composition for diagnosing cancer comprising same
CA2884820A1 (en) * 2012-09-14 2014-03-20 Memorial Sloan-Kettering Cancer Center Genes associated with dasatinib sensitivity
WO2014071316A1 (en) * 2012-11-02 2014-05-08 H. Lee Moffitt Cancer Center And Research Institute, Inc. In silico identification of cancer molecular signaling pathways and drug candidates
CN105190656B (en) 2013-01-17 2018-01-16 佩索纳里斯公司 Method and system for genetic analysis
CN103146821B (en) * 2013-02-25 2015-06-17 安徽农业大学 Method for evaluating inheritance effect of SNP (Single Nucleotide Polymorphism) sites to traits and application thereof
WO2014152377A1 (en) * 2013-03-14 2014-09-25 Vanderbilt University Methods for classifying and treating adenocarcinomas
WO2014150671A1 (en) * 2013-03-15 2014-09-25 The Broad Institute, Inc. Methods of identifying responses to map kinase inhibition therapy
US9920377B2 (en) * 2013-03-15 2018-03-20 Sutter West Bay Hospitals FALZ for use as a target for therapies to treat cancer
WO2014150751A2 (en) 2013-03-15 2014-09-25 Novartis Ag Biomarkers associated with brm inhibition
RU2528247C2 (en) * 2013-05-07 2014-09-10 Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН) Method of evaluation of sensitivity of lung cancer cells to doxorubicin based on expression levels of marker genes and set for its implementation
US9671391B2 (en) 2013-05-22 2017-06-06 Albert Einstein College Of Medicine, Inc. IL-34 receptor assays and uses thereof
ES2813877T3 (en) * 2013-08-28 2021-03-25 Crown Bioscience Inc Taicang Gene expression flags predictive of a subject's response to a multikinase inhibitor and methods of using the same
WO2015031689A1 (en) 2013-08-30 2015-03-05 Personalis, Inc. Methods and systems for genomic analysis
CN103525916B (en) * 2013-09-24 2016-06-15 浙江大学医学院附属第四医院 The test kit of assessment prognosis of HCC and the application of RFFL
WO2015051275A1 (en) 2013-10-03 2015-04-09 Personalis, Inc. Methods for analyzing genotypes
WO2015061348A1 (en) * 2013-10-21 2015-04-30 Memorial Sloan-Kettering Cancer Center Atrx as a companion diagnostic for cdk4 inhibitors
WO2015100257A1 (en) * 2013-12-23 2015-07-02 The General Hospital Corporation Methods and assays for determining reduced brca1 pathway function in a cancer cell
US20170003292A1 (en) * 2014-03-13 2017-01-05 H. Lee Moffitt Cancer Center And Research Institut Inc. Paxip1 as a biomarker for wee1 inhibitor therapy
US20150269307A1 (en) * 2014-03-18 2015-09-24 Texas Tech University System Target inhibition map system for combination therapy design and methods of using same
CN103969452B (en) * 2014-05-30 2016-04-20 中国人民解放军第二军医大学 The classification diagnosis kit of BAY 43-9006 personalized treatment liver cancer
US20170124268A1 (en) * 2014-06-25 2017-05-04 Koninklijke Philips N.V. System and method to assist patients and clinicians in using a shared and patient-centric decision support tool
US20170283882A1 (en) * 2014-09-05 2017-10-05 Duke University Methods and therapeutics relating to mrna biomarkers for clinical prognosis of cancer
WO2016070131A1 (en) 2014-10-30 2016-05-06 Personalis, Inc. Methods for using mosaicism in nucleic acids sampled distal to their origin
HUE057014T2 (en) * 2014-12-23 2022-04-28 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (hcc) and other cancers
JP2018523823A (en) * 2015-08-04 2018-08-23 セルジーン コーポレイション Treatment of chronic lymphocytic leukemia and use of biomarkers as predictors of clinical sensitivity to immunomodulatory therapy
US10720227B2 (en) 2015-08-12 2020-07-21 Samsung Electronics Co., Ltd. Method and device for mutation prioritization for personalized therapy
KR20170049024A (en) * 2015-10-28 2017-05-10 숙명여자대학교산학협력단 Composition for prevention or treating cancer comprising inhibitors for expression or activity of ANKs1a, and screening method for thereof
CN105483226B (en) * 2015-12-21 2018-06-19 中国人民解放军第三军医大学第三附属医院 A kind of method and kit for detecting STRAP gene transcription levels
US11299783B2 (en) 2016-05-27 2022-04-12 Personalis, Inc. Methods and systems for genetic analysis
EP3548633B1 (en) * 2016-12-01 2024-01-24 Oxford BioDynamics PLC Application of epigenetic chromsomal interactions in cancer diagnostics
WO2018130442A1 (en) * 2017-01-11 2018-07-19 Koninklijke Philips N.V. Method and system for automated inclusion or exclusion criteria detection
CN106729756B (en) * 2017-02-28 2021-05-25 青岛泱深生物医药有限公司 Application of biomarker as target in diagnosis and treatment of lung adenocarcinoma
CN108732349A (en) * 2017-04-20 2018-11-02 中国科学院上海生命科学研究院 LTA4H is as tubercle and the biomarker of early warning liver cancer in instruction liver
CN108732350A (en) * 2017-04-20 2018-11-02 中国科学院上海生命科学研究院 PLA2G6 is as tubercle and the biomarker of early warning liver cancer in instruction liver
CN108732351A (en) * 2017-04-20 2018-11-02 中国科学院上海生命科学研究院 EPS8L2 is as tubercle and the biomarker of early warning liver cancer in instruction liver
CN107881231A (en) * 2017-10-18 2018-04-06 中国人民解放军兰州军区兰州总医院 Application of the LMO3 genes in glioma antineoplastic is prepared
US20190249229A1 (en) * 2018-02-12 2019-08-15 Nant Holdings Ip, Llc Bam signatures from liquid and solid tumors and uses therefor
US11814750B2 (en) 2018-05-31 2023-11-14 Personalis, Inc. Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples
US10801064B2 (en) 2018-05-31 2020-10-13 Personalis, Inc. Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples
CN108841960B (en) * 2018-07-12 2022-02-01 吉林大学 Reagent box and system for colon adenocarcinoma susceptibility prediction
WO2020033585A1 (en) * 2018-08-07 2020-02-13 The Broad Institute, Inc. Methods for combinatorial screening and use of therapeutic targets thereof
CN110343759A (en) * 2019-06-03 2019-10-18 张鹏 The purposes of TRPV4 and its purposes of inhibitor and drug screening method
CN110423812B (en) * 2019-07-02 2023-07-25 南方医科大学 Use of Skiv2l2 (MTR 4) gene in tumor treatment
CN110687283B (en) * 2019-08-26 2023-05-23 中国医学科学院肿瘤医院 Use of autoantibodies in the diagnosis and/or treatment of tumors
CN110687284B (en) * 2019-08-26 2023-05-23 中国医学科学院肿瘤医院 Application of reagent for detecting SIX2 autoantibody in serum
CN110596403B (en) * 2019-09-17 2022-12-16 中山大学附属第一医院 Specific protein marker for ovarian cancer diagnosis and preparation method thereof
WO2021155192A1 (en) * 2020-01-30 2021-08-05 Thomas Jefferson University Compositions and methods of using cyanine dyes to target cancer and mitochondria
CN114231633B (en) * 2020-03-30 2022-05-20 中国医学科学院肿瘤医院 Application of exosomes ARPC5, STK3 and the like in lung cancer diagnosis
IT202000028628A1 (en) * 2020-11-26 2022-05-26 Ceinge Biotecnologie Avanzate S C A R L METHOD FOR PREDICTING THE FORMATION OF METASTASIS IN CANCER PATIENTS
CN112812179B (en) * 2021-01-19 2022-07-22 北京大学 High-affinity high-specificity anti-CMTM 6 monoclonal antibody and application thereof
KR102505355B1 (en) * 2021-04-16 2023-03-02 울산과학기술원 Method for screening therapeutic agents of cancer by interaction THRAP3 and DDX5
CN113652486B (en) * 2021-09-13 2023-02-03 新疆医科大学第四附属医院 Colorectal cancer treatment prognosis biomarker and application thereof
CN114277136B (en) * 2021-12-07 2023-09-22 武汉瑟文生物科技有限公司 Lung cancer gene marker based on ecDNA and application thereof
US20240095273A1 (en) * 2022-09-16 2024-03-21 Google Llc Actionable suggestions for media content
CN116482367A (en) * 2023-05-04 2023-07-25 中国中医科学院望京医院(中国中医科学院骨伤科研究所) Colorectal cancer detection method combining mSEPT9 detection and biomarker
CN117192127A (en) * 2023-08-18 2023-12-08 肇庆医学高等专科学校 Method for discovering HCC therapeutic target
CN117567651B (en) * 2024-01-15 2024-03-26 中国人民解放军东部战区总医院 Chimeric antigen receptor for synergistically expressing vascular endothelial adhesion molecule VCAM1 and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5436142A (en) * 1992-11-12 1995-07-25 Cold Spring Harbor Laboratory Methods for producing probes capable of distingushing variant genomic sequences
US20040197774A1 (en) * 1992-11-12 2004-10-07 Michael Wigler Representational approach to DNA analysis
AU2003214944A1 (en) * 2002-01-31 2003-09-02 Baylor College Of Medicine Secreted caveolin as a marker for prostate cancer
WO2007038792A2 (en) * 2005-09-28 2007-04-05 H. Lee Moffitt Cancer Center Individualized cancer treatments

Also Published As

Publication number Publication date
US20100130527A1 (en) 2010-05-27
EP2366162A1 (en) 2011-09-21
US10262103B2 (en) 2019-04-16
WO2010059742A1 (en) 2010-05-27

Similar Documents

Publication Publication Date Title
IL212905A0 (en) Individualized cancer dignosis
EP2280616A4 (en) Babybody
EP2257170A4 (en) Tetrahydrofuropyridones
EP2285758A4 (en) Fertilizer-pesticide throw-pack
EP2313147A4 (en) Morselizer
GB0801600D0 (en) Microtrench
EP2233305A4 (en) Printer-plotter
EP2285375A4 (en) Spiroazaindoles
GB0820166D0 (en) Former
GB0801589D0 (en) Mollusicide
GB0800389D0 (en) Gileo hang-it
GB0800161D0 (en) Rota-board
AU4098P (en) NPW2 Dianella tasmanica
AU3977P (en) PARV01 Myoporum parvifolium
AU3972P (en) Tobruk xTriticosecale
AU3935P (en) DPV308 Dianella prunina
GB0811114D0 (en) Mud-monster + tail-safe
GB0814118D0 (en) Property tycoon
GB0801969D0 (en) Ladderbar
GB0801789D0 (en) Scoosh-right
GB0801009D0 (en) Power-heal
GB0800935D0 (en) Kjbjkbk
GB0800902D0 (en) Gumtray
GB0800635D0 (en) Combi-cutter
GB0800531D0 (en) Webcanvas